close
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Covalon Technologies Ltd (OP:CVALF)

2.871 -0.022 (-0.74%)
Streaming Delayed Price Updated: 3:51 PM EDT, Sep 24, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 27,392
Open 2.910
Bid (Size) N/A (0)
Ask (Size) N/A (0)
Prev. Close 2.893
Today's Range 2.842 - 2.930
52wk Range 1.167 - 2.990
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Covalon Reports Encouraging Findings From Real World Evidence Analysis Comparing Collagen Dressings
From Covalon Technologies Ltd.
Via Business Wire
News headline image
Covalon Technologies Reports Significant Milestones Spanning Vascular Access, Infection Prevention, and Wound Care
From Covalon Technologies Ltd.
Via Business Wire

Performance

YTD
+109.6%
+109.6%
1 Month
+72.1%
+72.1%
3 Month
+84.0%
+84.0%
6 Month
+127.9%
+127.9%
1 Year
+79.4%
+79.4%

More News

Read More
News headline image
Covalon to Showcase Clinical Innovation and Infection Prevention Leadership at Infusion Nurses Society 2026 Annual Meeting
From Covalon Technologies Ltd.
Via Business Wire
News headline image
Covalon Honoured to Partner with the Association for Vascular Access and Global Expert Dr. Nancy Moureau to Tackle Critical IV Therapy Complications
From Covalon Technologies Ltd.
Via Business Wire
News headline image
Empowering Nurses with Innovation: Covalon Showcases Patient Safety Solutions to Tackle Preventable Complications at ANCC National Magnet & Pathway Conference
From Covalon Technologies Ltd.
Via Business Wire
News headline image
Covalon Presents Evidence-Backed Innovations Making a Difference for Critically Ill Children at APHON
From Covalon Technologies Ltd.
Via Business Wire
News headline image
Evidence-Driven Outcomes and Clinical Innovation Highlight Covalon’s Presence at the Association for Vascular Access 2025 Annual Meeting
From Covalon Technologies Ltd.
Via Business Wire
News headline image
Covalon Announces Publication of Impactful VALGuard® Line Guard Clinical Study Demonstrating Significant Reduction in Central Line-Associated Blood Stream Infections (CLABSIs)
From Covalon Technologies Ltd.
Via Business Wire
News headline image
Covalon Announces Exciting New Clinical Research Evaluating VALGuard® Vascular Access Line Guard
From Covalon Technologies Ltd.
Via Business Wire
News headline image
Covalon to Present at the 2025 Bloom Burton & Co. Healthcare Investor Conference on Tuesday, May 6, 2025
From Covalon Technologies Ltd.
Via Business Wire
News headline image
Covalon Announces Strong Fourth Quarter and Year End Fiscal 2024 Results
From Covalon Technologies Ltd.
Via Business Wire
News headline image
OTC Markets Group Announces the 2025 OTCQX Best 50
From OTC Markets
Via GlobeNewswire
News headline image
Covalon Technologies Highlights Compassionate Care Technologies at 2024 ANCC National Magnet Conference
From Covalon Technologies Ltd.
Via Business Wire
News headline image
Covalon Technologies Ltd. to Participate in the 2024 Association for Vascular Access Annual Scientific Meeting
From Covalon Technologies Ltd.
Via Business Wire
News headline image
Covalon to Present at the Planet MicroCap Showcase: VANCOUVER 2024 in association with Small Cap Discoveries on Thursday, September 26, 2024 at 10:00 a.m. PST
Via ACCESSWIRE
News headline image
Covalon Announces Profitable Second Quarter Fiscal 2024 Results
From Covalon Technologies Ltd.
Via Business Wire
News headline image
Covalon Presents Compassionate Care Technology at the Infusion Nurses Society (INS) Annual Meeting & Exhibition in Kansas City, MO
From Covalon Technologies Ltd.
Via Business Wire
News headline image
Covalon Announces First Quarter Fiscal 2024 Results
From Covalon Technologies Ltd.
Via Business Wire
News headline image
Covalon’s VALGuard Gains Prestigious Recognition in the British Journal of Nursing
From Covalon Technologies Ltd.
Via Business Wire
News headline image
Covalon Presents Innovative Solutions Used in Top Hospitals at the Association for Vascular Access (AVA) Annual Scientific Meeting in Portland, OR
From Covalon Technologies Ltd.
Via Business Wire
News headline image
Covalon to Showcase Innovative Solutions at the Prestigious ANCC National Magnet Conference in Chicago
From Covalon Technologies Ltd.
Via Business Wire
News headline image
Life with a Central Line [WEBINAR]: Key Considerations from the Patient’s Perspective
From Covalon Technologies Ltd.
Via Business Wire
News headline image
Covalon Showcases Compassionate Pediatric Care Solutions at 47th APHON Conference
From Covalon Technologies Ltd.
Via Business Wire
News headline image
Premier Medical Journal Spotlights Covalon’s VALGUARD: A Novel Solution to Long-Standing Problem of Protecting Vascular Access Sites
From Covalon Technologies Ltd.
Via Business Wire
News headline image
Covalon Announces Participation in Oley Conference in St. Louis, Missouri on June 27 – 30, 2023
From Covalon Technologies Ltd.
Via Business Wire

Frequently Asked Questions

Is Covalon Technologies Ltd publicly traded?
Yes, Covalon Technologies Ltd is publicly traded.
What exchange does Covalon Technologies Ltd trade on?
Covalon Technologies Ltd trades on the OTC Traded
What is the ticker symbol for Covalon Technologies Ltd?
The ticker symbol for Covalon Technologies Ltd is CVALF on the OTC Traded
What is the current price of Covalon Technologies Ltd?
The current price of Covalon Technologies Ltd is 2.871
When was Covalon Technologies Ltd last traded?
The last trade of Covalon Technologies Ltd was at 09/24/26 03:51 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Starting at /week.